Pharma Japan
Subscription Required: Yes
Pharma Japan provides up-to-date news, insights, and analysis on the Japanese pharmaceutical industry, including regulatory changes, market trends, and company developments. LATEST NEWS
- G1 Reform Will Accelerate LLP Transfers, Fuel Competition: LTL Chief
- Daiichi Sankyo’s I-DXd Filed in US for SCLC, Wins Priority Review
- JPMA to Launch Nitrosamine Risk Project for APIs in FY2026
- MHLW Taps Kawabata to Lead Drug Discovery Support Office
- Nxera’s Partner Earns Taiwan Approval for Daridorexant
- MHLW Reviewing EMIS Data on Petro-Product Supply to Medical Institutions
- Sanofi Japan Sales Rise 4.5% in 2025 as Dupixent Widens Label